Hinge Health Statistics
Total Valuation
Hinge Health has a market cap or net worth of $3.62 billion. The enterprise value is $3.15 billion.
Important Dates
The last earnings date was Tuesday, February 10, 2026, after market close.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hinge Health has 78.76 million shares outstanding. The number of shares has increased by 302.55% in one year.
| Current Share Class | 55.82M |
| Shares Outstanding | 78.76M |
| Shares Change (YoY) | +302.55% |
| Shares Change (QoQ) | +7.20% |
| Owned by Insiders (%) | 18.67% |
| Owned by Institutions (%) | 54.90% |
| Float | 35.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.31 |
| PS Ratio | 6.16 |
| Forward PS | 4.93 |
| PB Ratio | 20.37 |
| P/TBV Ratio | 32.31 |
| P/FCF Ratio | 21.21 |
| P/OCF Ratio | 21.12 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 18.46 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.47 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.86% and return on invested capital (ROIC) is -83.87%.
| Return on Equity (ROE) | -132.86% |
| Return on Assets (ROA) | -48.16% |
| Return on Invested Capital (ROIC) | -83.87% |
| Return on Capital Employed (ROCE) | -142.90% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $388,283 |
| Profits Per Employee | -$280,110 |
| Employee Count | 1,514 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 8.94 |
Taxes
In the past 12 months, Hinge Health has paid $998,000 in taxes.
| Income Tax | 998,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 41.87 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 63.60 |
| Average Volume (20 Days) | 1,886,151 |
Short Selling Information
The latest short interest is 4.16 million, so 5.28% of the outstanding shares have been sold short.
| Short Interest | 4.16M |
| Short Previous Month | 4.77M |
| Short % of Shares Out | 5.28% |
| Short % of Float | 11.87% |
| Short Ratio (days to cover) | 2.75 |
Income Statement
In the last 12 months, Hinge Health had revenue of $587.86 million and -$424.09 million in losses. Loss per share was -$7.77.
| Revenue | 587.86M |
| Gross Profit | 469.30M |
| Operating Income | -546.37M |
| Pretax Income | -527.26M |
| Net Income | -424.09M |
| EBITDA | -544.24M |
| EBIT | -546.37M |
| Loss Per Share | -$7.77 |
Full Income Statement Balance Sheet
The company has $363.86 million in cash and $8.04 million in debt, with a net cash position of $469.00 million or $5.95 per share.
| Cash & Cash Equivalents | 363.86M |
| Total Debt | 8.04M |
| Net Cash | 469.00M |
| Net Cash Per Share | $5.95 |
| Equity (Book Value) | 378.54M |
| Book Value Per Share | 2.26 |
| Working Capital | 171.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $171.44 million and capital expenditures -$708,000, giving a free cash flow of $170.73 million.
| Operating Cash Flow | 171.44M |
| Capital Expenditures | -708,000 |
| Free Cash Flow | 170.73M |
| FCF Per Share | $2.17 |
Full Cash Flow Statement Margins
Gross margin is 79.83%, with operating and profit margins of -92.94% and -89.86%.
| Gross Margin | 79.83% |
| Operating Margin | -92.94% |
| Pretax Margin | -89.69% |
| Profit Margin | -89.86% |
| EBITDA Margin | -92.58% |
| EBIT Margin | -92.94% |
| FCF Margin | 29.04% |
Dividends & Yields
Hinge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -302.55% |
| Shareholder Yield | -302.55% |
| Earnings Yield | -11.71% |
| FCF Yield | 4.72% |
Analyst Forecast
The average price target for Hinge Health is $58.25, which is 26.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $58.25 |
| Price Target Difference | 26.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 19.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hinge Health has an Altman Z-Score of 2.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.91 |
| Piotroski F-Score | 4 |